The Net Margin of Kyongbo Pharmaceutical Co Ltd (214390.KS) is 1.94%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 1.94% |
| 2023-12-31 | 1.37% |
| 2022-12-31 | 0.31% |
| 2021-12-31 | -4.39% |
| 2020-12-31 | 4.37% |
| 2019-12-31 | 2.76% |
| 2018-12-31 | 6.51% |
| 2017-12-31 | 9.37% |
| 2016-12-31 | 6.80% |
| 2015-12-31 | 14.67% |